{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:58:00Z","timestamp":1782370680692,"version":"3.54.5"},"reference-count":132,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.pharmthera.2005.05.003","type":"journal-article","created":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T17:38:07Z","timestamp":1119375487000},"page":"281-293","source":"Crossref","is-referenced-by-count":49,"title":["Using animal models to develop therapeutics for Tourette Syndrome"],"prefix":"10.1016","volume":"108","author":[{"given":"Neal R.","family":"Swerdlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.05.003_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/104454604773840562","article-title":"Use of the \u201cinverse neuroleptic\u201d metoclopramide in Tourette syndrome: an open case series","volume":"14","author":"Acosta","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.WNL.0000076181.39162.FC","article-title":"Increased ventral striatal monoaminergic innervation in Tourette syndrome","volume":"61","author":"Albin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib3","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1212\/01.WNL.0000123111.00324.BF","article-title":"Ropinirole in Gilles de la Tourette syndrome","volume":"62","author":"Anca","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.1992.01820090009002","article-title":"Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive\u2013compulsive disorder","volume":"49","author":"Baxter","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1531-8257(200011)15:6<1194::AID-MDS1019>3.0.CO;2-H","article-title":"Response to levodopa challenge in Tourette syndrome","volume":"15","author":"Black","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archpsyc.1980.01780250029002","article-title":"Sensory experiences of Gilles de la Tourette syndrome","volume":"37","author":"Bliss","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-8760(99)00019-7","article-title":"Attentional modulation of short- and long-lead-interval modification of the acoustic startle eyeblink response: comparing auditory and visual prestimuli","volume":"32","author":"Bohmelt","year":"1999","journal-title":"Int J Psychophysiol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1469-8986.1978.tb01390.x","article-title":"Prestimulus effects on human startle reflex in normals and schizophrenics","volume":"15","author":"Braff","year":"1978","journal-title":"Psychophysiology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/npp.1993.64","article-title":"The functional neuroanatomy of Tourette's syndrome: an FDG-PET study: I. Regional changes in cerebral glucose metabolism differentiating patients and controls","volume":"9","author":"Braun","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib11","first-page":"29","article-title":"Risperidone as a treatment for Tourette's syndrome","volume":"57","author":"Bruun","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4088\/JCP.v62n0412","article-title":"An open-label study of the treatment efficacy of olanzapine for Tourette's disorder","volume":"62","author":"Budman","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib13","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1097\/00001756-200007140-00053","article-title":"TS+OCD-like neuropotentiated mice are supersensitive to seizure induction","volume":"11","author":"Campbell","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0028-3908(98)00051-3","article-title":"Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats","volume":"37","author":"Carasso","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib15","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-3223(95)00101-8","article-title":"Sensorimotor gating in boys with Tourette's Syndrome and ADHD: preliminary results","volume":"39","author":"Castellanos","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib17","first-page":"319","article-title":"Sensory phenomena associated with Gilles de la Tourette's syndrome","volume":"5","author":"Cohen","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00437617","article-title":"Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine","volume":"43","author":"Costall","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1037\/h0040957","article-title":"Construct validity in psychological tests","volume":"52","author":"Cronbach","year":"1955","journal-title":"Psychol Bull"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2004.02.032","article-title":"Premature responding following bilateral stimulation of the rat subthalamic nucleus is amplitude and frequency dependent","volume":"1008","author":"Desbonnet","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib141","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","article-title":"Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial","volume":"22","author":"Dion","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2460\/javma.1994.204.08.1219","article-title":"Equine self-mutilation syndrome (57 cases)","volume":"204","author":"Dodman","year":"1994","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib23","unstructured":"Dunne, R. (2004). How surgery helped me beat Tourettes'. BBC News. Retrieved from http:\/\/news.bbc.co.uk\/1\/hi\/health\/3591401.stm"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002130050125","article-title":"Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT2A receptors are active under physiological conditions","volume":"128","author":"Dursun","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib25","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(94)90388-3","article-title":"Longlasting improvement of Tourette's syndrome with transdermal nicotine","volume":"344","author":"Dursun","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.48.4.927","article-title":"The metabolic anatomy of Tourette's syndrome","volume":"48","author":"Eidelberg","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0024-3205(99)00040-5","article-title":"Potentiation of haloperidol catalepsy by microinjections of nicotine into the striatum or pons in rats","volume":"64","author":"Elazar","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0091-3057(91)90256-2","article-title":"Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity","volume":"38","author":"Emerich","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib30","first-page":"3","article-title":"On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats","volume":"50","author":"Fog","year":"1972","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nn1038","article-title":"Epigenetic sources of behavioral differences in mice","volume":"6","author":"Francis","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1126\/science.124.3215.264","article-title":"Apomorphine test for tranquilizing drugs: effect of dibenamine","volume":"124","author":"Freedman","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/104454603322572516","article-title":"Obsessive\u2013compulsive disorder, Tourette's disorder, or pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in an adolescent? Diagnostic and therapeutic challenges","volume":"13","author":"Gabbay","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib142","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004583-200203000-00013","article-title":"Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome","volume":"41","author":"Gaffney","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130000558","article-title":"Effects of nicotine on head-shakes and tryptophan metabolites","volume":"153","author":"Gaynor","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/01.WNL.0000044058.64647.7E","article-title":"Tic reduction with pergolide in a randomized controlled trial in children","volume":"60","author":"Gilbert","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archneur.1984.04050150049015","article-title":"Fluphenazine and multifocal tic disorders","volume":"41","author":"Goetz","year":"1984","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib38","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archneur.55.9.1233","article-title":"Sensory modulation of the blink reflex in patients with blepharospasm","volume":"55","author":"Gomez-Wong","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1469-8986.1975.tb01284.x","article-title":"The more or less startling effects of weak prestimuli","volume":"12","author":"Graham","year":"1975","journal-title":"Psychophysiology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1017\/S109285290001899X","article-title":"Mechanisms and the current state of deep brain stimulation in neuropsychiatry","volume":"8","author":"Greenberg","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s002210050930","article-title":"The parafascicular nucleus and two-way active avoidance: effects of electrical stimulation and electrode implantation","volume":"129","author":"Guillazo-Blanch","year":"1999","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004583-200202000-00017","article-title":"Genetics of childhood disorders: XXXV. Autoimmune disorders: Part 8. Animal models for noninflammatory autoimmune disorders of the brain","volume":"41","author":"Hallett","year":"2002","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-5728(00)00320-9","article-title":"Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction","volume":"111","author":"Hallett","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pbb.2003.08.015","article-title":"Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome","volume":"76","author":"Hayslett","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02246184","article-title":"Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability","volume":"120","author":"Hoffman","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib46","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1523\/JNEUROSCI.0887-03.2004","article-title":"A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection","volume":"24","author":"Hoffman","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib47","article-title":"A jangling journey: life with Tourette's syndrome","volume":"5","author":"Hollenbeck","year":"2003","journal-title":"Cerebrum"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.eurpsy.2003.11.002","article-title":"Clinical and attentional effects of acute nicotine treatment in Tourette's syndrome","volume":"19","author":"Howson","year":"2004","journal-title":"Eur Psychiatr"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib50","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.34.5.688","article-title":"Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome","volume":"34","author":"Jankovic","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib51","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.286.5445.1745","article-title":"Building neural representations of habits","volume":"286","author":"Jog","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1542\/peds.92.1.39","article-title":"Antineuronal antibodies in movement disorders","volume":"92","author":"Kiessling","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib53","first-page":"233","article-title":"Stress-induced stereotypy in the rat: neuropharmacological similarities to Tourette syndrome","volume":"35","author":"Knott","year":"1982","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0925-4927(02)00123-3","article-title":"Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects","volume":"122","author":"Kumari","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib55","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1542\/peds.113.4.883","article-title":"The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive\u2013compulsive symptoms: hypothesis or entity? Practical considerations for the clinician","volume":"113","author":"Kurlan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib56","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/mds.10618","article-title":"Premonitory sensory phenomenon in Tourette's syndrome","volume":"18","author":"Kwak","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","article-title":"Clonidine treatment of Gilles de la Tourette's syndrome","volume":"48","author":"Leckman","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1176\/ajp.150.1.98","article-title":"Premonitory urges in Tourette's syndrome","volume":"150","author":"Leckman","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.151.5.675","article-title":"\u201cJust right\u201d perceptions associated with compulsive behavior in Tourette's syndrome","volume":"151","author":"Leckman","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbr.2004.04.014","article-title":"Prepulse inhibition of the acoustic startle reflex in pigs and its disruption by d-amphetamine","volume":"155","author":"Lind","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib61","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00213-003-1533-8","article-title":"Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys","volume":"169","author":"Linn","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/npp.1993.44","article-title":"Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia","volume":"9","author":"Lipska","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib63","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/mds.10522","article-title":"Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes","volume":"19","author":"Loiselle","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib64","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","article-title":"Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial","volume":"56","author":"Marras","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib65","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/0006-3223(92)90315-Q","article-title":"The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder","volume":"31","author":"McConville","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(00)02646-9","article-title":"Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive\u2013compulsive disorder","volume":"877","author":"McGrath","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1192\/bjp.170.2.140","article-title":"Phenomenological differences appearing with repetitive behaviours in obsessive\u2013compulsive disorder and Gilles de la Tourette's syndrome","volume":"170","author":"Miguel","year":"1997","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib68","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4088\/JCP.v61n0213","article-title":"Sensory phenomena in obsessive\u2013compulsive disorder and Tourette's disorder","volume":"61","author":"Miguel","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib69","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0887-8994(01)00262-4","article-title":"Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis","volume":"25","author":"Mink","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.167.2.249","article-title":"Brain perfusion abnormalities in Gilles de la Tourette's syndrome","volume":"167","author":"Moriarty","year":"1995","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/104454603322572624","article-title":"Quetiapine treatment of children and adolescents with Tourette's disorder","volume":"13","author":"Mukaddes","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette's syndrome with delta 9-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"Muller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib75","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1101\/lm.74704","article-title":"AX+, BX\u2212 discrimination learning in the fear-potentiated startle paradigm: possible relevance to inhibitory fear learning in extinction","volume":"11","author":"Myers","year":"2004","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0920-1211(90)90098-G","article-title":"Stargazer: a new neurological mutant on chromosome 15 in the mouse with prolonged cortical seizures","volume":"7","author":"Noebels","year":"1990","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib77","doi-asserted-by":"crossref","unstructured":"Nordstrom, E. J., & Burton, F. H. (2002). A transgenic model of comorbid Tourette's syndrome and obsessive\u2013compulsive disorder circuitry. Mol Psychiatry 7, 617\u2013625, 524.","DOI":"10.1038\/sj.mp.4001144"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib79","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1469-8986.1992.tb01717.x","article-title":"Prestimulation-induced startle modulation in attention deficit hyperactivity disorder and nocturnal enuresis","volume":"29","author":"Ornitz","year":"1992","journal-title":"Psychophysiology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib80","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/070674370104600220","article-title":"Quetiapine treatment in patients with Tourette syndrome","volume":"46","author":"Parraga","year":"2001","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib81","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0006-3223(98)00176-0","article-title":"The temporal dynamics of tics in Gilles de la Tourette syndrome","volume":"44","author":"Peterson","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib82","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/WNL.43.5.941","article-title":"Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images","volume":"43","author":"Peterson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib83","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archpsyc.55.4.326","article-title":"A functional magnetic resonance imaging study of tic suppression in Tourette syndrome","volume":"55","author":"Peterson","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib84","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.60.4.415","article-title":"Basal Ganglia volumes in patients with Gilles de la Tourette syndrome","volume":"60","author":"Peterson","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-3956(74)90062-4","article-title":"Pharmacology and physiology of stereotyped behavior","volume":"11","author":"Randrup","year":"1974","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib86","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1994.03950010062008","article-title":"Regional cerebral blood flow measured during symptom provocation in obsessive\u2013compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography","volume":"51","author":"Rauch","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib87","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/jnnp.49.7.791","article-title":"Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome","volume":"49","author":"Regeur","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib88","first-page":"207","article-title":"SPECT imaging of cerebral bloodflow in Tourette syndrome","volume":"58","author":"Riddle","year":"1992","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00002826-199006000-00005","article-title":"Management of Gilles de la Tourette syndrome using sulpiride","volume":"13","author":"Robertson","year":"1990","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib91","first-page":"585","article-title":"A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette syndrome","volume":"155","author":"Ross","year":"1978","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib92","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","article-title":"Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder","volume":"154","author":"Sallee","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib93","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","article-title":"Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study","volume":"39","author":"Sallee","year":"2000","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib94","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(88)91388-8","article-title":"Nicotine gum and haloperidol in Tourette's syndrome","volume":"1","author":"Sanberg","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib95","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0753-3322(89)90186-8","article-title":"Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome","volume":"43","author":"Sanberg","year":"1989","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(96)00199-4","article-title":"Nicotine for the treatment of Tourette's syndrome","volume":"74","author":"Sanberg","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00207450108986527","article-title":"Mecamylamine effects on haloperidol-induced catalepsy and defecation","volume":"109","author":"Sanberg","year":"2001","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib98","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0883-9417(93)90029-V","article-title":"Tourette's syndrome: Part II. Contemporary approaches to assessment and treatment","volume":"7","author":"Scahill","year":"1993","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib99","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00207459608987247","article-title":"Event-related potentials during an auditory discrimination with prepulse inhibition in patients with schizophrenia, obsessive\u2013compulsive disorder and healthy subjects","volume":"84","author":"Schall","year":"1996","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib101","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1192\/S0007125000297882","article-title":"Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive\u2013compulsive disorder. An evolving perspective on brain and behaviour","author":"Schwartz","year":"1998","journal-title":"Br J Psychiatr Suppl"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib102","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","article-title":"Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome","volume":"46","author":"Shapiro","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00003072-199303000-00022","article-title":"Tc-99m HMPAO SPECT brain imaging of Gilles de la Tourette's syndrome","volume":"18","author":"Sieg","year":"1993","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0140-6736(93)91392-Y","article-title":"Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome","volume":"342","author":"Silver","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib107","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/cap.2000.10.59","article-title":"Mecamylamine in Tourette's syndrome: a two-year retrospective case study","volume":"10","author":"Silver","year":"2000","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib108","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v62n0908","article-title":"Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study","volume":"62","author":"Silver","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib109","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00004583-200109000-00020","article-title":"Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder","volume":"40","author":"Silver","year":"2001","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib111","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/jnnp.52.7.895","article-title":"Abnormalities of the blink reflex in Gilles de la Tourette syndrome","volume":"52","author":"Smith","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib113","first-page":"179","article-title":"Cortico-striatal substrates of cognitive, motor and sensory gating: speculations and implications for psychological function and dysfunction","volume":"vol. 2","author":"Swerdlow","year":"1996"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib114","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.schbul.a033326","article-title":"Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia","volume":"24","author":"Swerdlow","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S0140525X00047488","article-title":"Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function","volume":"10","author":"Swerdlow","year":"1987","journal-title":"Behav Brain Sci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib116","unstructured":"Swerdlow, N. R., & Sutherland, A. N. (in press). Preclinical Models Relevant to Tourette Syndrome. In J. H. Walkup et al. (Eds.), Tourette Syndrome, Philadelphia: Lippincott, Williams and Wilkins."},{"key":"10.1016\/j.pharmthera.2005.05.003_bib117","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S1092852900000833","article-title":"Neuropathology in Tourette Syndrome","volume":"4","author":"Swerdlow","year":"1999","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib118","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0006-3223(93)90300-3","article-title":"A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder","volume":"33","author":"Swerdlow","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib119","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1994.03950020063007","article-title":"Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenic patients","volume":"51","author":"Swerdlow","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jnnp.58.2.192","article-title":"Impaired prepulse inhibition of acoustic and tactile startle in patients with Huntington's Disease","volume":"58","author":"Swerdlow","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib121","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00008877-200006000-00002","article-title":"Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon","volume":"111","author":"Swerdlow","year":"2000","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib122","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","article-title":"Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges","volume":"156","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib123","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0006-3223(01)01164-7","article-title":"Tactile pre-puff inhibition of startle in children with Tourette's syndrome: in search of an \u201cfMRI friendly\u201d startle paradigm","volume":"50","author":"Swerdlow","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib124","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130100856","article-title":"Effects of pergolide on sensorimotor gating of the startle reflex in rats","volume":"158","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib125","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(02)03298-5","article-title":"Startle gating in rats is disrupted by chemical inactivation but not D2 stimulation of the dorsomedial thalamus","volume":"953","author":"Swerdlow","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib126","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1037\/0735-7044.116.4.672","article-title":"Prestimulus effects on startle magnitude: sensory or motor?","volume":"116","author":"Swerdlow","year":"2002","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib143","first-page":"164s","article-title":"Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: Implications for predictive validity and Tourette syndrome","volume":"57","author":"Swerdlow","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib127","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1176\/appi.ajp.159.4.657","article-title":"An animal model of Tourette's syndrome","volume":"159","author":"Taylor","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib128","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0278-5846(01)00194-4","article-title":"Nicotine attenuates DOI-induced head-twitch response in mice: implications for Tourette syndrome","volume":"25","author":"Tizabi","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib129","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics: a randomized controlled trial","volume":"58","author":"Tourette's Syndrome Study Group","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib130","first-page":"663.7","article-title":"A monkey model of Tourette's syndrome: induction of hyperactivity disorder with attention deficit (HD\/AD) and stereotypy by microinjections of Bicuculline in the external segment of global pallidus","author":"Tremblay","year":"2002","journal-title":"Abstr Soc Neurosci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib131","first-page":"595","article-title":"Stargazer (stg), new deafness mutant in the Zucker rat","volume":"44","author":"Truett","year":"1994","journal-title":"Lab Anim Sci"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib132","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0893-133X(00)00164-0","article-title":"Birth insult alters dopamine-mediated behavior in a precocial species, the guinea pig. Implications for schizophrenia","volume":"23","author":"Vaillancourt","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib133","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.clinph.2004.02.014","article-title":"Abnormalities of prepulse inhibition do not depend on blink reflex excitability: a study in Parkinson's disease and Huntington's disease","volume":"115","author":"Valls-Sole","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib134","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0005-7967(03)00154-2","article-title":"Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study","volume":"42","author":"Verdellen","year":"2004","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib135","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3171\/jns.2003.99.6.1094","article-title":"Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases","volume":"99","author":"Visser-Vandewalle","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib136","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/appi.ajp.160.6.1175","article-title":"Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial","volume":"160","author":"Wilhelm","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal models of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib137","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0278-5846(86)90051-5","article-title":"Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case","volume":"10","author":"Willner","year":"1986","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib139","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0163-7258(90)90076-E","article-title":"Animal models of depression: an overview","volume":"45","author":"Willner","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.05.003_bib140","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1176\/ajp.154.9.1277","article-title":"Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation","volume":"154","author":"Ziemann","year":"1997","journal-title":"Am J Psychiatry"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T02:49:30Z","timestamp":1706323770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725805001002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":132,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0163725805001002"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.05.003","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}